Dr Daniel Kalman Podolsky, MD | |
1801 Inwood Road,, 6th Floor, Suite 102, Dallas, TX 75390 | |
(214) 645-0595 | |
(214) 645-0581 |
Full Name | Dr Daniel Kalman Podolsky |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 1801 Inwood Road,, Dallas, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316929375 | NPI | - | NPPES |
#8BQ932 | Other | TX | BLUE CROSS/BLUE SHIELD OF TEXAS |
0152579 | Medicaid | MA | |
045936 | Other | MA | TUFTS HEALTH PLAN |
E05681 | Other | MA | BCBS MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 45936 (Massachusetts) | Secondary |
207RG0100X | Internal Medicine - Gastroenterology | 42347 (Texas) | Primary |
Entity Name | University Of Texas Southwestern Medical Center At Dallas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Patients who are responding below par to the anticoagulant drug warfarin have several options. They can undergo even more blood tests to monitor their response to the different dosages of this medication which is prescribed to prevent strokes, or they could start using one of the newer, yet more expensive, anticoagulants on the market.
Taking herbal food supplements is certainly not free of risk. Since 2005, the poison emergency centers in the German cities of Freiburg and Gottingen have registered a total of 17 patients with health problems after taking Chinese slimming capsules.
TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.
Merck & Co., Inc. will hold its third-quarter 2009 sales and earnings conference call with institutional investors and analysts beginning at 9:00 a.m. EDT on Thursday, Oct. 22. During the call, Richard T. Clark, chairman, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Kenneth C. Frazier, executive vice president and president, Global Human Health, will provide an overview of Merck's financial performance for the quarter.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Kalman Podolsky, MD 5323 Harry Hines Boulevard, (b12.100), Dallas, TX 75390-9002 Ph: (214) 648-2508 | Dr Daniel Kalman Podolsky, MD 1801 Inwood Road,, 6th Floor, Suite 102, Dallas, TX 75390 Ph: (214) 645-0595 |
News Archive
Patients who are responding below par to the anticoagulant drug warfarin have several options. They can undergo even more blood tests to monitor their response to the different dosages of this medication which is prescribed to prevent strokes, or they could start using one of the newer, yet more expensive, anticoagulants on the market.
Taking herbal food supplements is certainly not free of risk. Since 2005, the poison emergency centers in the German cities of Freiburg and Gottingen have registered a total of 17 patients with health problems after taking Chinese slimming capsules.
TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.
Merck & Co., Inc. will hold its third-quarter 2009 sales and earnings conference call with institutional investors and analysts beginning at 9:00 a.m. EDT on Thursday, Oct. 22. During the call, Richard T. Clark, chairman, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Kenneth C. Frazier, executive vice president and president, Global Human Health, will provide an overview of Merck's financial performance for the quarter.
› Verified 4 days ago
Uma B.r.k Pakkivenkata, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |